To check the efficacy of vruddha darak sama churna in Rheumatoid Arthritis

Randomised Clinical Study On Vruddha Darak Sama Churna In The Management Of Amavata (Rheumatoid Arthritis). - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081111

Enrollment

Registered

2025-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients presenting with the signs and symptoms of Amavata. b) Patients of either sex aged between 20 - 60 years. c) Patient having signs and symptoms of Amavata upto 3 yrs.

Exclusion criteria

Exclusion criteria: a) Patients suffering from acute systemic disorders as well as other known case if major illness like Cancer, HIV AIDS, Gouty Arthritis, Syphilis, Tuberculosis, Gonococcal Infections etc. b) Pregnant or Lactating women. c) Rheumatic fever ,cardiac complications, valvular heart disease, rheumatic heart disease, complication and modified part of RA i.e. erosion of bones, ligaments, complete stiffness ,joint fixation . d) Patient dependant on oral steroids and or DMARD drugs.

Design outcomes

Primary

Measure	Time frame
Reduction in the signs and symptoms of Amavata. Timepoint: 30 days	—

Secondary

Measure	Time frame
Comparative effect of Vruddha darak sama churna and Ajamodadya Churna in the management of Amavata.Timepoint: 7th 14th 28th day	—

Countries

India

Contacts

Public ContactDr Sanjay Dhurve

Bharati Vidyapeeth (Deemed to be University)

sanjay.dhurve@bharatividyapeeth.edu9850044207

Outcome results